Portfolio Category: Medical Devices-Digital Health

Vitalunga, an Israeli Biomedical startup led by Prof. Shmuel (Muli) Ben-Sasson and Prof. Einav Gross, The Hebrew University’s Faculty of Medicine, has developed a family of novel small-molecule drugs that precisely enhances autophagy and mitophagy. This platform technology opens the way for the treatment and prevention of multiple aging-associated diseases such as Alzheimer’s and Parkinson’s diseases, congestive heart failure, sarcopenia, AMD etc., utilizing a single oral agent.

Personalized risk assessment and treatment decision platform. Imaging cancer lesions and blood tests for cancer detection.

Aferrix is an innovative leader in development and applications of novel tools for early diagnosis and monitoring of toxic iron in the serum. The company has developed several methods that quantify different forms of toxic iron in the serum, which are not detected by conventional tests. Aferrix offers iron testing services and kits for research and treatment centers that specialize in iron over load diseases (Thalassemia, Hemochromatosis, Myelodysplastic syndrome) and to pharmaceutical companies that are developing iron chelators. The company was founded by Prof. Zvi Ioav Cabantchik, Department of Biological Chemistry, Alexander Silberman Institute of Life Sciences, Hebrew University of Jerusalem, Jerusalem, Israel.

Nexocarp offers novel micro-encapsulation solutions in liquid and powder formulas to accelerate the sustainable transformation of products. All industries, especially Agriculture and Food-Tech will benefit from these long-lasting safe solutions which also safeguard the environment.